SCHEMBL2889753

SCHEMBL2889753

COc1ccc(-c2ccc(CCl)c(Cl)c2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 1/20 0.44
ABCB1 P08183 1/20 0.44
BCR P11274 1/20 0.44
ERCC5 P28715 1/20 0.44
FEN1 P39748 1/20 0.44
ALDH1A1 P00352 2/20 0.44
GFER P55789 1/20 0.44
RAB9A P51151 2/20 0.43
NPC1 O15118 1/20 0.43
TP53 P04637 1/20 0.43
MAPK1 P28482 1/20 0.43
CASP3 P42574 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
SENP8 Q96LD8 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
SENP6 Q9GZR1 1/20 0.43
ESR2 Q92731 1/20 0.42
DYRK1A Q13627 2/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4510419 0.85 ALDH1A1 (0.53) ALDH1A1GFERDYRK1AKDM4ECA12
SCHEMBL2298426 0.81 CYP11B1 (0.46) ABL1ABCB1BCRALDH1A1GFER
SCHEMBL7342450 0.79 LTA4H (0.54) ABL1ABCB1BCRERCC5FEN1
SCHEMBL2092168 0.79 AHR (0.61) ABL1ABCB1BCRERCC5FEN1
SCHEMBL6308178 0.77 ESR2 (0.53) ERCC5FEN1ALDH1A1SMN1; SMN2ESR2
SCHEMBL12603887 0.76 TAS1R3 (0.49) ABL1ABCB1BCRERCC5FEN1
SCHEMBL2790208 0.76 AHR (0.39) ALDH1A1RAB9AMAPK1ESR2MEN1
SCHEMBL473994 0.74 SLC6A4 (0.45) ALDH1A1GFERESR2MEN1KMT2A
SCHEMBL11695594 0.74 MAPT (0.54) ABL1ABCB1BCRERCC5FEN1
SCHEMBL9144848 0.73 ALDH1A1 (0.53) ALDH1A1GFERDYRK1AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7700653-B2 Halogen-substituted aminodicarboxylic acid derivatives BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-04-20 US disclosed
US-20060111444-A1 Novel halogen-substituted aminodicarboxylic acid derivatives BAYER AKTIENGESELLSCHAFT (DE) 2006-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060111444-A1 Novel halogen-substituted aminodicarboxylic acid derivatives FABP3, PPARD, FABP1 ABL1 557/4885ABCB1 1111/4885BCR 1087/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.